SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-044419
Filing Date
2024-04-15
Accepted
2024-04-15 16:17:08
Documents
19
Period of Report
2024-04-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K apvo-20240410.htm   iXBRL 8-K 52902
2 EX-4.1 apvo-ex4_1.htm EX-4.1 158824
3 EX-4.2 apvo-ex4_2.htm EX-4.2 156153
4 EX-10.1 apvo-ex10_1.htm EX-10.1 158887
5 EX-10.2 apvo-ex10_2.htm EX-10.2 320346
6 EX-99.1 apvo-ex99_1.htm EX-99.1 14946
7 EX-99.2 apvo-ex99_2.htm EX-99.2 13598
8 GRAPHIC img237228349_0.jpg GRAPHIC 4584
9 GRAPHIC img238151870_0.jpg GRAPHIC 4584
  Complete submission text file 0000950170-24-044419.txt   1154123

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT apvo-20240410.xsd EX-101.SCH 26036
22 EXTRACTED XBRL INSTANCE DOCUMENT apvo-20240410_htm.xml XML 4925
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

IRS No.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37746 | Film No.: 24844841
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)